Effects of Tirzepatide in Obesity-Related HFpEF by Sex: A Prespecified Secondary Analysis From the SUMMIT Trial.

Saved in:
Bibliographic Details
Title: Effects of Tirzepatide in Obesity-Related HFpEF by Sex: A Prespecified Secondary Analysis From the SUMMIT Trial.
Authors: Borlaug BA; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: borlaug.barry@mayo.edu., Zile MR; Division of Cardiology, Medical University of South Carolina and the Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina, USA., Kramer CM; Cardiovascular Division, Department of Medicine, and Department of Radiology and Medical Imaging, University of Virginia Health, Charlottesville, Virginia, USA., Litwin SE; Division of Cardiology, Medical University of South Carolina and the Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina, USA., Ye W; Eli Lilly and Company, Indianapolis, Indiana, USA., Ou Y; Eli Lilly and Company, Indianapolis, Indiana, USA., Hurt K; Eli Lilly and Company, Indianapolis, Indiana, USA., Murakami M; Eli Lilly and Company, Indianapolis, Indiana, USA., Packer M; Baylor University Medical Center, Dallas, Texas, USA; Imperial College, London, United Kingdom.
Corporate Authors: SUMMIT Trial Group
Source: JACC. Heart failure [JACC Heart Fail] 2026 Jul 07, pp. 103218. Date of Electronic Publication: 2026 Jul 07.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101598241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-1787 (Electronic) Linking ISSN: 22131779 NLM ISO Abbreviation: JACC Heart Fail Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2213-1787
DOI:10.1016/j.jchf.2026.103218